These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29352267)

  • 1. Differential susceptibility of striatal, hippocampal and cortical neurons to Caspase-6.
    Noël A; Zhou L; Foveau B; Sjöström PJ; LeBlanc AC
    Cell Death Differ; 2018 Jul; 25(7):1319-1335. PubMed ID: 29352267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment.
    LeBlanc AC; Ramcharitar J; Afonso V; Hamel E; Bennett DA; Pakavathkumar P; Albrecht S
    Cell Death Differ; 2014 May; 21(5):696-706. PubMed ID: 24413155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits.
    Noël A; Foveau B; LeBlanc AC
    Cell Death Dis; 2021 Mar; 12(3):227. PubMed ID: 33649324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice.
    Zhou L; Flores J; Noël A; Beauchet O; Sjöström PJ; LeBlanc AC
    Acta Neuropathol Commun; 2019 Dec; 7(1):210. PubMed ID: 31843022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.
    Schmidt ME; Buren C; Mackay JP; Cheung D; Dal Cengio L; Raymond LA; Hayden MR
    BMC Biol; 2018 Jun; 16(1):58. PubMed ID: 29945611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment.
    Flores J; Noël A; Fillion ML; LeBlanc AC
    Cell Death Differ; 2022 Mar; 29(3):657-669. PubMed ID: 34625662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-6 activity predicts lower episodic memory ability in aged individuals.
    Ramcharitar J; Afonso VM; Albrecht S; Bennett DA; LeBlanc AC
    Neurobiol Aging; 2013 Jul; 34(7):1815-24. PubMed ID: 23402898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington disease.
    Kolodziejczyk K; Parsons MP; Southwell AL; Hayden MR; Raymond LA
    PLoS One; 2014; 9(4):e94562. PubMed ID: 24728353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment.
    Foveau B; Albrecht S; Bennett DA; Correa JA; LeBlanc AC
    Acta Neuropathol Commun; 2016 Dec; 4(1):127. PubMed ID: 27931265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo.
    Graham RK; Deng Y; Carroll J; Vaid K; Cowan C; Pouladi MA; Metzler M; Bissada N; Wang L; Faull RL; Gray M; Yang XW; Raymond LA; Hayden MR
    J Neurosci; 2010 Nov; 30(45):15019-29. PubMed ID: 21068307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.
    Maheshwari M; Samanta A; Godavarthi SK; Mukherjee R; Jana NR
    J Biol Chem; 2012 Aug; 287(35):29949-57. PubMed ID: 22787151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease.
    Rué L; Alcalá-Vida R; López-Soop G; Creus-Muncunill J; Alberch J; Pérez-Navarro E
    Neuromolecular Med; 2014 Mar; 16(1):25-37. PubMed ID: 23896721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
    Giampà C; Laurenti D; Anzilotti S; Bernardi G; Menniti FS; Fusco FR
    PLoS One; 2010 Oct; 5(10):e13417. PubMed ID: 20976216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells.
    Kim HA; Jiang L; Madsen H; Parish CL; Massalas J; Smardencas A; O'Leary C; Gantois I; O'Tuathaigh C; Waddington JL; Ehrlich ME; Lawrence AJ; Drago J
    Neurobiol Dis; 2014 Feb; 62():323-37. PubMed ID: 24135007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
    Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
    J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice.
    Uribe V; Wong BK; Graham RK; Cusack CL; Skotte NH; Pouladi MA; Xie Y; Feinberg K; Ou Y; Ouyang Y; Deng Y; Franciosi S; Bissada N; Spreeuw A; Zhang W; Ehrnhoefer DE; Vaid K; Miller FD; Deshmukh M; Howland D; Hayden MR
    Hum Mol Genet; 2012 May; 21(9):1954-67. PubMed ID: 22262731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
    Ehrnhoefer DE; Caron NS; Deng Y; Qiu X; Tsang M; Hayden MR
    Exp Neurol; 2016 Sep; 283(Pt A):121-8. PubMed ID: 27296315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.